Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity - Concepedia

Concepedia

Publication | Open Access

Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity

DOI Full Paper Access

154

Citations

43

References

2014

Year

Jonathan D. Graves, Jennifer J. Kordich, Tzu-Hsuan Huang, Julia Piasecki, Tammy L. Bush, Timothy J. Sullivan, Ian N. Foltz, Wesley Chang, Heather Douangpanya, Thu Thi Dang,

Antitumor ActivityG Protein-coupled ReceptorMedicineFunctional SelectivityApoptosisImmunologyReceptor (Biochemistry)Cell DeathAnti-cancer AgentPromote Receptor ClusteringPharmacologyDeath Receptor 5

References

	Year	Citations

Page 1

Page 1